+

US20060083795A1 - Meal replacement products having appetite suppressing qualities - Google Patents

Meal replacement products having appetite suppressing qualities Download PDF

Info

Publication number
US20060083795A1
US20060083795A1 US11/253,234 US25323405A US2006083795A1 US 20060083795 A1 US20060083795 A1 US 20060083795A1 US 25323405 A US25323405 A US 25323405A US 2006083795 A1 US2006083795 A1 US 2006083795A1
Authority
US
United States
Prior art keywords
meal replacement
caralluma
hoodia
group
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/253,234
Inventor
Lima Shatkina
Rufina Shatkina
Sam Gurevich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/253,234 priority Critical patent/US20060083795A1/en
Priority to PCT/US2005/038239 priority patent/WO2006045112A2/en
Priority to EP05811893A priority patent/EP1804585A4/en
Publication of US20060083795A1 publication Critical patent/US20060083795A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya

Definitions

  • Drugs are sometimes used to lower food intake by suppressing appetite.
  • Centrally acting appetite suppressant drugs used in the treatment of obesity fall into two broad pharmacological categories; those which act via brain catecholamine pathways and those which act via serotonin pathways.
  • amphetamine and phenmetrazine are no longer recommended because of their stimulant properties and addictive potential.
  • Some of the remaining drugs in the group that act via brain catecholamine include amfepramone (diethylpropion), phentermine, mazindol and phenylpropanolamine.
  • amfepramone diethylpropion
  • phentermine phentermine
  • mazindol mazindol
  • phenylpropanolamine phenylpropanolamine.
  • Most, if not all, of these remaining drugs have been shown to reduce appetite and lower food intake, thereby helping obese patients more easily keep to a low-calorie diet and lose weight.
  • most if not all of these remaining drugs have some sympathom
  • anorectic drugs which promote serotonin neurotransmission may not have such stimulant or sympathomimetic properties.
  • Drugs which act via serotonin pathways may include fenfluramine, together with its recently introduced dextrorotatory stereoisomer dexfenfluramine, and fluoxetine. These drugs reduce appetite and food intake and are effective in the treatment of obesity. Anorectic drugs are frequently reserved for those who are clinically at risk from being overweight, and then as part of a comprehensive weight-reducing program including regular dietary counseling.
  • dexfenfluramine appears to have the most suitable pharmacological profile, although it should not be given to patients with a history of depression. Meal replacements are meant to be taken instead of a meal, but unlike after a meal, one is typically still hungry after a meal replacement.
  • the meal replacement includes a meal replacement base, and an appetite suppressant including a succulent plant extract.
  • the succulent plant extract which may be a dry powder, juice, pulp, or any other form is selected from the group consisting of Trichocaulon piliferum, Trichocaulon officinale, Hoodia gordonii, Hoodia currorii, Hoodia lugardii , and the Caralluma group of plants.
  • a meal replacement product having an appetite suppressing qualities, due to an added succulent plant extract that may be in the form of a powder, a juice, a pulp, or any other form, as a method of combating obesity in a human or “animal” by appetite suppression and thus lowering calorie intake.
  • appetite suppressant shall broadly be used to indicate activity, which tends to limit appetite and/or increase the sense of satiety, to reduce total calorific intake; this in turn tends to counteract obesity. Accordingly, this exemplary system and method extends to a method of treating, preventing or combating obesity in a human or non-human animal.
  • the succulent powder/extract includes at least one succulent plant selected from the group including Trichocaulon piliferum, Trichocaulon officinale, Hoodia gordonii, Hoodia currorii, Hoodia lugardii , and the Caralluma group of plants.
  • Other exemplary ingredients may be included with these powder/extracts to form the meal replacement.
  • the meal replacement may be used instead of a meal, as a snack between the meals, or as a meal and/or a snack any time of the day.
  • the term “animal” as used here extends to, but is not restricted to, companion animals, e.g.
  • the present exemplary system and method for providing a meal replacement formula includes a food item including an extract from a plant of the genus Trichocaulon , genus Hoodia , and/or from a plant of the genus Caralluma that comprises an appetite suppressant agent. Additionally, the meal replacement food item may also include a meal replacement base including a sugar substitute, protein, fiber, vitamins, minerals, and/or neutraceuticals, among other ingredients. Further details of each of the exemplary ingredients and their functions will be provided below.
  • a meal replacement formula contains an extract obtainable from a plant of the genus Trichocaulon , genus Hoodia , and/or from a plant of the genus Caralluma that comprises an appetite suppressant agent.
  • Extracts from the genus Trichocaulon may be selected from the species Trichocaulon piliferum and Trichocaulon officinale .
  • Extracts from plants of the genus Hoodia may be selected from the species Hoodia currorii, Hoodia gordonii and Hoodia lugardii .
  • Extracts from the genus Caralluma may be selected from the species fimbriata, attenuata, tuberculata, adscendens , and indica .
  • An extract of succulent plant may be present in any form and concentration, or as a fine powdered dry succulent plant or succulent juice.
  • Hoodia is a genus of succulent plants in the family Apocynaceae.
  • the dry extract of Hoodia Gordonii may allow a person to reduce food consumption relatively effortlessly, with little or no side effects and with no substantial loss of vitality.
  • Hoodia Gordonii has a similar but far greater effect than glucose on the brain's nerve cells yet without any of the calories.
  • a molecule was isolated in the hoodia that sends messages to the brain signaling that caloric needs have been met thus satiating appetite, like does glucose. But contrary to glucose, this molecule does not generate any calories.
  • Clinical studies have also shown that, due at least in part to this appetite suppressant, obese patients using the supplement can reduce their calorie intake by 30 to 40%, thus significantly improving their weight loss.
  • Hoodia Gordonii may aid in helping reestablish the true alimentary needs of a patient, when used in conjunction with a healthy, balanced, sufficient diet.
  • Hoodia Currorii which is eaten as a food, may also work as an appetite suppressant and to treat indigestion, hypertension, diabetes and stomach ache.
  • the Caralluma group of plants belongs to the Asclepiadaceae family and includes a number of species. Some of these species include but are not limited to: caralluma indica, caralluma fimbriata, caralluma attenuata, caralluma tuberculata, caralluma edulis, caralluma adscendens, caralluma stalagmifera, caralluma umbellata, caralluma penicillata, caralluma russeliana, caralluma retrospiciens, caralluma arabica and caralluma lasiantha . Some of the species are distributed throughout various parts of India. Caralluma plants are small, erect and fleshy.
  • the Indian species of the Caralluma plant have four grooved stems that are almost round in shape. Plants of this species are generally devoid of leaves and form small flowers in a variety of dark colors.
  • the Indian Caralluma plants frequently have pods that are erect, linear and about 2.5 cms in length and feel velvety to the touch.
  • the thorns of Caralluma are soft.
  • the species of Caralluma found in India are edible.
  • Caralluma The medicinal properties of Caralluma includes carminative, febrifugal, anthelmintic, anti-rheumatic, anti-diabetic and anti-hyperglycaemic, anti-pyretic, anti-inflammatory, anti-nociceptive, and anti-oxidant effects.
  • the Caralluma extracts have been also found to be appetite-suppressants as well as CNS stimulants.
  • a glycoside is a condensation product obtained from a sugar and non-sugar compound and may have further components such as ring structures that are substituted or non-substituted.
  • the glycosides contained in Caralluma belong to the pregnane group of glycosides.
  • Meal replacement if in a form of a proprietary shake mix is preferably low in carbohydrate and low in sugar.
  • the carbohydrate and sugar content of a mix can be reduced by replacing natural sugar sweeteners with sugar substitutes.
  • Sugar substitutes do not significantly increase blood sugar levels and therefore do not count as net effective carbohydrates.
  • the sugar substitutes used may include sugar alcohols, high intensity sweeteners, fiber sweeteners or combinations thereof.
  • Sugar alcohols are well-suited for use as sugar substitutes in low carbohydrate foods.
  • Exemplary sugar alcohols can be up to about 95% as sweet as sucrose, and provide similar bulking properties as sucrose.
  • Sugar alcohols are low-digestible carbohydrates because they are not fully absorbed from the intestines; thus, they provide fewer calories than sucrose and are less available for energy metabolism. Because of these properties, sugar alcohols do not cause the detrimental effects on diabetics that other carbohydrates cause.
  • sugar alcohols examples include, but are not limited to, mannitol, sorbitol, xylitol, lactitol, isomalt, maltitol, erythritol, D-tagatose, trehalose, isomalt and hydrogenated starch hydrolysates (HSH). Additionally, maltitol solution and other sugar alcohol solutions may be used to improve the texture, moisture content and crystallization properties of the low carbohydrate foods.
  • the sugar alcohol is isomalt, a sugar substitute produced by the isomerisation and catalytic hydrogenation of sucrose, with subsequent solidification and milling. Since it is based on sucrose, isomalt can be substituted for natural sugar or any other sugar alcohol in a 1:1 mass ratio.
  • sugar substitutes that can also be used include fiber sweeteners such as inulin and oligofructose.
  • Inulin and oligofructose provide sweetness, as well as add bulk and creaminess. Inulin and oligofructose are thus useful as fat replacements, are good sources of soluble dietary fiber and are well-suited for diabetics because they do not increase the blood sugar level or insulin level due to their indigestible nature.
  • the fiber sweeteners can be used in addition to, or in place of, sugar alcohols.
  • the sugar substitute comprises inulin instead of sugar alcohols in order to further reduce or eliminate net effective carbohydrates.
  • gums such as guar gum, gum arabic, xanthan gum, carrageenan and pectin, can be added with the inulin to help improve the texture and to minimize or neutralize carbohydrates.
  • High intensity sweeteners can also be as sugar substitutes to reduce the net effective carbohydrate content of food while still providing a sweet taste. These high intensity sweeteners can be used in addition to, or in place of, sugar alcohols and fiber sweeteners. These sweeteners can be hundreds of times sweeter than sucrose, yet they contain many fewer calories than sucrose. High intensity sweeteners also have little to no effect on blood sugar levels.
  • High intensity sweeteners include, but are not limited to, aspartame, alitame, neotame, cyclamates, saccharin, acesulfame, sucralose, neohesperidin dihydrochalcone, stevia sweeteners, glycyrrhizin, thaumatin, and the like, and mixtures thereof.
  • the amount of high intensity sweetener used is scant since it has such an intense sweetness.
  • the present exemplary meal replacement will support anyone wanting a healthy meal with limited carbohydrates, particularly persons seeking to control carbohydrate and sugar intake, lose weight, curb their appetite, and/or boost their energy level. It also offers a support to individuals with Type II Diabetes or those who are at risk to develop it. This is relevant not only as a method of treatment short-term weight control but also long-term weight maintenance.
  • the meal replacement is also suitable for those on a low-carbohydrate diet.
  • the appetite suppressing meal replacement base may also include any kinds and amounts of protein, fibers, vitamins/minerals/fruits and vegetable extracts, neutraceuticals, botanicals and any other edible ingredients.
  • the meal replacement may contain protein material in order to provide additional nutritional benefits and an alternative from the traditional method for supplying protein in a diet.
  • the protein material that can be used includes, but is not limited to, soy and soy isolates, whey and whey isolates, micro cross filtered whey isolates, wheat proteins (e.g., glutenir, gliadin, and gluten), isolated grain and vegetable proteins, egg white protein, protein isolates, and albumen isolates.
  • Vegetable proteins include any vegetable in which proteins may be collected, whether condensed, accumulated or isolated.
  • protein-providing vegetables examples include spelt, quinoa, amaranth, buckwheat, black rice and the like.
  • the protein material can be any single type of protein, or may be a blend of various proteins that provides unique texture, flavor, durability and strength characteristics to the ingesting medium based on the composition of the blend.
  • Fiber may also be used to give good mouth feel and to reduce the net effective carbohydrate content.
  • the fiber that may be used in the present system and method includes plant-based fibers, such as those derived from vegetables, legumes, fruits and grains.
  • the fiber may be soluble or insoluble, and includes, but is not limited to, non-starch polysaccharides, resistant starches, modified starches, lignin and fructo-oligosaccharides.
  • fructo-oligosaccharides are not technically fibers, they are classified as dietary fiber since they are not absorbed in the intestine, and therefore have a zero net carbohydrate effect.
  • suitable fructo-oligosaccharide fiber include inulin and oligofructose.
  • a fiber rich diet may also be desirable to help alleviate or prevent conditions including constipation, diverticulosis, colon and rectal cancer, heart disease, breast cancer, diabetes and obesity.
  • the meal replacement can also act as an ideal carrier for vitamins and minerals.
  • vitamins that can be added to the ingested medium include, but are not limited to, vitamin A, vitamin B 12 , vitamin C, vitamin D, vitamin E, vitamin K, para-aminobenzoic acid, Vitamin B 2 (riboflavin), Vitamin B 6 , niacin, inositol, biotin, folic acid, choline, and vitamin B 1 .
  • vitamins that can be added to the ingested medium include, but are not limited to, vitamin A, vitamin B 12 , vitamin C, vitamin D, vitamin E, vitamin K, para-aminobenzoic acid, Vitamin B 2 (riboflavin), Vitamin B 6 , niacin, inositol, biotin, folic acid, choline, and vitamin B 1 .
  • minerals that can be added include, but are not limited to, magnesium, iron, zinc, copper, manganese, sodium, potassium, calcium, selenium, chromium, mo
  • the meal replacement can also contain botanicals (neutraceuticals) including, but not limited to, bilberry, cascara, cat's claw, cayenne, cranberry, devil's claw, dong quai, echinacea, evening primrose oil, feverfew, garlic, ginger, ginkgo, Asian ginseng, Siberian ginseng, goldenseal, gotu kola, grape seed, green tea, hawthorn, kava, licorice, milk thistle, noni, saw palmetto, St.
  • botanicals including, but not limited to, bilberry, cascara, cat's claw, cayenne, cranberry, devil's claw, dong quai, echinacea, evening primrose oil, feverfew, garlic, ginger, ginkgo, Asian ginseng, Siberian ginseng, goldenseal, gotu kola, grape seed, green tea, hawthorn, kava, licorice, milk this
  • the meal replacement can be in the form of a dry powder mix, to be reconstituted with water, milk, or juice, or in ready to drink packaging, any edible/drinkable form, any form of nutritional beverages, puddings, confections (i.e., candy), ice cream, frozen confections and novelties, hot chocolate, coffee, tea, juice, confectionaries, chocolates, probiotic drinks/yogurt/kefir, nutritional/energy bars, soups, breads/cereals, chips and etc.
  • any edible/drinkable form any form of nutritional beverages, puddings, confections (i.e., candy), ice cream, frozen confections and novelties, hot chocolate, coffee, tea, juice, confectionaries, chocolates, probiotic drinks/yogurt/kefir, nutritional/energy bars, soups, breads/cereals, chips and etc.
  • the ingredients of the nutritional supplement can be administered separately, such as by incorporating certain components (e.g., bitter tasting ones) into a capsule or tablet and the remaining ingredients are provided as a powder or nutritional bar.
  • certain components e.g., bitter tasting ones
  • the appetite suppressing extract used in meal replacement could be prepared from plant material such as the stems and roots of said plants of the genus Trichocaulon or of the genus Hoodia .
  • the genus Trichocaulon and the genus Hoodia include succulent plants growing in arid regions such as are found in Southern Africa. Besides possessing appetite suppressing and thirst quenching qualities, hoodia also possesses a sense of well being, and, anecdotal accounts regarding its aphrodisiac properties.
  • the present exemplary system and method extends also to a composition or formulation having appetite suppressant activity, in which the active ingredient is a synthetically produced version of Hoodia Gordonii , a member of the Caralluma group or a derivative or analogue thereof.
  • the present exemplary system and method extends also to a foodstuff or a beverage containing an effective quantity of the appetite suppressing Hoodia species, or its derivatives or analogues as set out before, to have an appetite suppressant effect when ingested.
  • a powder form which is reconstituted with water, milk or juice
  • the powder is to be mixed in any kind of ways, as in an electric blender or by simply shaking/stirring the powder and the liquid in a container.
  • the powder could be agglomerated to facilitate reconstitution without an electric food blender.
  • a weight control meal replacement is formulated such that one serving of the beverage/bar/chocolate/soup/etc, acts as a meal replacement and provides any amount of United States Recommended Daily Allowance (US RDA) for protein, minerals and vitamins, fiber, and any amount of calories.
  • US RDA United States Recommended Daily Allowance

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Pediatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cultivation Of Plants (AREA)

Abstract

A meal replacement is provided herein. According to one exemplary embodiment, the meal replacement includes a meal replacement base, and an appetite suppressant including a succulent plant extract. According to one exemplary embodiment, the succulent plant extract is selected from the group consisting of Trichocaulon piliferum, Trichocaulon officinale, Hoodia gordonii, Hoodia currorii, Hoodia lugardii, and the Caralluma group of plants.

Description

    RELATED APPLICATION
  • The present application is related to a previously filed U.S. provisional patent application entitled “Meal Replacement Product Having Appetite Suppressing Qualities,” filed Oct. 19, 2004 and having a Ser. No. 60/620,195, the contents of which are hereby incorporated by reference in their entirety.
    • BACKGROUND
  • Drugs are sometimes used to lower food intake by suppressing appetite. Centrally acting appetite suppressant drugs used in the treatment of obesity fall into two broad pharmacological categories; those which act via brain catecholamine pathways and those which act via serotonin pathways. Of the group that act via brain catecholamine, amphetamine and phenmetrazine are no longer recommended because of their stimulant properties and addictive potential. Some of the remaining drugs in the group that act via brain catecholamine include amfepramone (diethylpropion), phentermine, mazindol and phenylpropanolamine. Most, if not all, of these remaining drugs have been shown to reduce appetite and lower food intake, thereby helping obese patients more easily keep to a low-calorie diet and lose weight. Further, most if not all of these remaining drugs have some sympathomimetic and stimulant properties that produce effects similar to the “fight or flight” response, which cause increased heart rate, sweating, and increased blood pressure.
  • Other drugs which act via serotonin pathways may not have such effects. In particular, anorectic drugs which promote serotonin neurotransmission may not have such stimulant or sympathomimetic properties. Drugs which act via serotonin pathways may include fenfluramine, together with its recently introduced dextrorotatory stereoisomer dexfenfluramine, and fluoxetine. These drugs reduce appetite and food intake and are effective in the treatment of obesity. Anorectic drugs are frequently reserved for those who are clinically at risk from being overweight, and then as part of a comprehensive weight-reducing program including regular dietary counseling. Although current licensing regulations only allow their use over a relatively short period, such as about twelve to sixteen weeks, clinical trials have shown that these drugs may be effective over longer periods, particularly in preventing weight regain. Of the compounds currently indicated for use in obesity, dexfenfluramine appears to have the most suitable pharmacological profile, although it should not be given to patients with a history of depression. Meal replacements are meant to be taken instead of a meal, but unlike after a meal, one is typically still hungry after a meal replacement.
    • SUMMARY
  • A meal replacement is provided herein. According to one exemplary embodiment, the meal replacement includes a meal replacement base, and an appetite suppressant including a succulent plant extract. According to one exemplary embodiment, the succulent plant extract, which may be a dry powder, juice, pulp, or any other form is selected from the group consisting of Trichocaulon piliferum, Trichocaulon officinale, Hoodia gordonii, Hoodia currorii, Hoodia lugardii, and the Caralluma group of plants.
    • DETAILED DESCRIPTION
  • The following description includes specific details in order to provide a thorough understanding of the novel meal replacement and appetite suppressant. Skilled artisan will understand, however, that the products and methods described below can be practiced without employing these specific details. Indeed, they can be modified and can be used in conjunction with products and techniques known to those of skill in the art.
  • A meal replacement product is provided herein having an appetite suppressing qualities, due to an added succulent plant extract that may be in the form of a powder, a juice, a pulp, or any other form, as a method of combating obesity in a human or “animal” by appetite suppression and thus lowering calorie intake. As used herein, “appetite suppressant” shall broadly be used to indicate activity, which tends to limit appetite and/or increase the sense of satiety, to reduce total calorific intake; this in turn tends to counteract obesity. Accordingly, this exemplary system and method extends to a method of treating, preventing or combating obesity in a human or non-human animal. According to one exemplary embodiment, the succulent powder/extract includes at least one succulent plant selected from the group including Trichocaulon piliferum, Trichocaulon officinale, Hoodia gordonii, Hoodia currorii, Hoodia lugardii, and the Caralluma group of plants. Other exemplary ingredients may be included with these powder/extracts to form the meal replacement. The meal replacement may be used instead of a meal, as a snack between the meals, or as a meal and/or a snack any time of the day. The term “animal” as used here extends to, but is not restricted to, companion animals, e.g. household pets and domesticated animals; non-limiting examples of such animals include cattle, sheep, ferrets, swine, camels, horses, poultry, fish, rabbits, goats, dogs and cats. Exemplary succulent powder/extracts will first be discussed, followed by a discussion of other optional ingredients.
  • The present exemplary system and method for providing a meal replacement formula includes a food item including an extract from a plant of the genus Trichocaulon, genus Hoodia, and/or from a plant of the genus Caralluma that comprises an appetite suppressant agent. Additionally, the meal replacement food item may also include a meal replacement base including a sugar substitute, protein, fiber, vitamins, minerals, and/or neutraceuticals, among other ingredients. Further details of each of the exemplary ingredients and their functions will be provided below.
  • According to one exemplary embodiment, a meal replacement formula contains an extract obtainable from a plant of the genus Trichocaulon, genus Hoodia, and/or from a plant of the genus Caralluma that comprises an appetite suppressant agent. Extracts from the genus Trichocaulon may be selected from the species Trichocaulon piliferum and Trichocaulon officinale. Extracts from plants of the genus Hoodia may be selected from the species Hoodia currorii, Hoodia gordonii and Hoodia lugardii. Extracts from the genus Caralluma may be selected from the species fimbriata, attenuata, tuberculata, adscendens, and indica. An extract of succulent plant may be present in any form and concentration, or as a fine powdered dry succulent plant or succulent juice.
  • Hoodia is a genus of succulent plants in the family Apocynaceae. The dry extract of Hoodia Gordonii may allow a person to reduce food consumption relatively effortlessly, with little or no side effects and with no substantial loss of vitality. Hoodia Gordonii has a similar but far greater effect than glucose on the brain's nerve cells yet without any of the calories. A molecule was isolated in the hoodia that sends messages to the brain signaling that caloric needs have been met thus satiating appetite, like does glucose. But contrary to glucose, this molecule does not generate any calories. Clinical studies have also shown that, due at least in part to this appetite suppressant, obese patients using the supplement can reduce their calorie intake by 30 to 40%, thus significantly improving their weight loss. Consequently, Hoodia Gordonii may aid in helping reestablish the true alimentary needs of a patient, when used in conjunction with a healthy, balanced, sufficient diet. Hoodia Currorii, which is eaten as a food, may also work as an appetite suppressant and to treat indigestion, hypertension, diabetes and stomach ache.
  • The Caralluma group of plants belongs to the Asclepiadaceae family and includes a number of species. Some of these species include but are not limited to: caralluma indica, caralluma fimbriata, caralluma attenuata, caralluma tuberculata, caralluma edulis, caralluma adscendens, caralluma stalagmifera, caralluma umbellata, caralluma penicillata, caralluma russeliana, caralluma retrospiciens, caralluma arabica and caralluma lasiantha. Some of the species are distributed throughout various parts of India. Caralluma plants are small, erect and fleshy. The Indian species of the Caralluma plant have four grooved stems that are almost round in shape. Plants of this species are generally devoid of leaves and form small flowers in a variety of dark colors. The Indian Caralluma plants frequently have pods that are erect, linear and about 2.5 cms in length and feel velvety to the touch. The thorns of Caralluma are soft. The species of Caralluma found in India are edible.
  • The medicinal properties of Caralluma includes carminative, febrifugal, anthelmintic, anti-rheumatic, anti-diabetic and anti-hyperglycaemic, anti-pyretic, anti-inflammatory, anti-nociceptive, and anti-oxidant effects. The Caralluma extracts have been also found to be appetite-suppressants as well as CNS stimulants.
  • The medicinal properties of Caralluma have been attributed to the glycosides contained therein. A glycoside is a condensation product obtained from a sugar and non-sugar compound and may have further components such as ring structures that are substituted or non-substituted. The glycosides contained in Caralluma belong to the pregnane group of glycosides.
  • Meal replacement if in a form of a proprietary shake mix, is preferably low in carbohydrate and low in sugar. The carbohydrate and sugar content of a mix can be reduced by replacing natural sugar sweeteners with sugar substitutes. Sugar substitutes do not significantly increase blood sugar levels and therefore do not count as net effective carbohydrates. The sugar substitutes used may include sugar alcohols, high intensity sweeteners, fiber sweeteners or combinations thereof.
  • Sugar alcohols are well-suited for use as sugar substitutes in low carbohydrate foods. Exemplary sugar alcohols can be up to about 95% as sweet as sucrose, and provide similar bulking properties as sucrose. Sugar alcohols are low-digestible carbohydrates because they are not fully absorbed from the intestines; thus, they provide fewer calories than sucrose and are less available for energy metabolism. Because of these properties, sugar alcohols do not cause the detrimental effects on diabetics that other carbohydrates cause. Examples of suitable sugar alcohols include, but are not limited to, mannitol, sorbitol, xylitol, lactitol, isomalt, maltitol, erythritol, D-tagatose, trehalose, isomalt and hydrogenated starch hydrolysates (HSH). Additionally, maltitol solution and other sugar alcohol solutions may be used to improve the texture, moisture content and crystallization properties of the low carbohydrate foods. In another aspect the sugar alcohol is isomalt, a sugar substitute produced by the isomerisation and catalytic hydrogenation of sucrose, with subsequent solidification and milling. Since it is based on sucrose, isomalt can be substituted for natural sugar or any other sugar alcohol in a 1:1 mass ratio.
  • Other sugar substitutes that can also be used include fiber sweeteners such as inulin and oligofructose. Inulin and oligofructose provide sweetness, as well as add bulk and creaminess. Inulin and oligofructose are thus useful as fat replacements, are good sources of soluble dietary fiber and are well-suited for diabetics because they do not increase the blood sugar level or insulin level due to their indigestible nature. Generally the fiber sweeteners can be used in addition to, or in place of, sugar alcohols. In one embodiment, the sugar substitute comprises inulin instead of sugar alcohols in order to further reduce or eliminate net effective carbohydrates. In another embodiment gums, such as guar gum, gum arabic, xanthan gum, carrageenan and pectin, can be added with the inulin to help improve the texture and to minimize or neutralize carbohydrates.
  • High intensity sweeteners can also be as sugar substitutes to reduce the net effective carbohydrate content of food while still providing a sweet taste. These high intensity sweeteners can be used in addition to, or in place of, sugar alcohols and fiber sweeteners. These sweeteners can be hundreds of times sweeter than sucrose, yet they contain many fewer calories than sucrose. High intensity sweeteners also have little to no effect on blood sugar levels. High intensity sweeteners include, but are not limited to, aspartame, alitame, neotame, cyclamates, saccharin, acesulfame, sucralose, neohesperidin dihydrochalcone, stevia sweeteners, glycyrrhizin, thaumatin, and the like, and mixtures thereof. Usually the amount of high intensity sweetener used is scant since it has such an intense sweetness.
  • The present exemplary meal replacement will support anyone wanting a healthy meal with limited carbohydrates, particularly persons seeking to control carbohydrate and sugar intake, lose weight, curb their appetite, and/or boost their energy level. It also offers a support to individuals with Type II Diabetes or those who are at risk to develop it. This is relevant not only as a method of treatment short-term weight control but also long-term weight maintenance. The meal replacement is also suitable for those on a low-carbohydrate diet.
  • The appetite suppressing meal replacement base may also include any kinds and amounts of protein, fibers, vitamins/minerals/fruits and vegetable extracts, neutraceuticals, botanicals and any other edible ingredients. For example, the meal replacement may contain protein material in order to provide additional nutritional benefits and an alternative from the traditional method for supplying protein in a diet. The protein material that can be used includes, but is not limited to, soy and soy isolates, whey and whey isolates, micro cross filtered whey isolates, wheat proteins (e.g., glutenir, gliadin, and gluten), isolated grain and vegetable proteins, egg white protein, protein isolates, and albumen isolates. Vegetable proteins include any vegetable in which proteins may be collected, whether condensed, accumulated or isolated. Examples of protein-providing vegetables include spelt, quinoa, amaranth, buckwheat, black rice and the like. The protein material can be any single type of protein, or may be a blend of various proteins that provides unique texture, flavor, durability and strength characteristics to the ingesting medium based on the composition of the blend.
  • Fiber may also be used to give good mouth feel and to reduce the net effective carbohydrate content. The fiber that may be used in the present system and method includes plant-based fibers, such as those derived from vegetables, legumes, fruits and grains. The fiber may be soluble or insoluble, and includes, but is not limited to, non-starch polysaccharides, resistant starches, modified starches, lignin and fructo-oligosaccharides. Although fructo-oligosaccharides are not technically fibers, they are classified as dietary fiber since they are not absorbed in the intestine, and therefore have a zero net carbohydrate effect. Examples of suitable fructo-oligosaccharide fiber include inulin and oligofructose. A fiber rich diet may also be desirable to help alleviate or prevent conditions including constipation, diverticulosis, colon and rectal cancer, heart disease, breast cancer, diabetes and obesity.
  • The meal replacement can also act as an ideal carrier for vitamins and minerals. Examples of vitamins that can be added to the ingested medium include, but are not limited to, vitamin A, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, para-aminobenzoic acid, Vitamin B2 (riboflavin), Vitamin B6, niacin, inositol, biotin, folic acid, choline, and vitamin B1. Examples of minerals that can be added include, but are not limited to, magnesium, iron, zinc, copper, manganese, sodium, potassium, calcium, selenium, chromium, molybdenum, chlorine, fluorine, phosphorus, sulfur, and iodine. The meal replacement can also contain botanicals (neutraceuticals) including, but not limited to, bilberry, cascara, cat's claw, cayenne, cranberry, devil's claw, dong quai, echinacea, evening primrose oil, feverfew, garlic, ginger, ginkgo, Asian ginseng, Siberian ginseng, goldenseal, gotu kola, grape seed, green tea, hawthorn, kava, licorice, milk thistle, noni, saw palmetto, St. John's wort, valerian, melatonin, damiana, yerbe mate, guarana, Rhodiola Rosea, camu-camu berries, Wolfberries, Acai, borojoa patinoi, and the like.
  • The meal replacement can be in the form of a dry powder mix, to be reconstituted with water, milk, or juice, or in ready to drink packaging, any edible/drinkable form, any form of nutritional beverages, puddings, confections (i.e., candy), ice cream, frozen confections and novelties, hot chocolate, coffee, tea, juice, confectionaries, chocolates, probiotic drinks/yogurt/kefir, nutritional/energy bars, soups, breads/cereals, chips and etc.
  • In another embodiment, the ingredients of the nutritional supplement can be administered separately, such as by incorporating certain components (e.g., bitter tasting ones) into a capsule or tablet and the remaining ingredients are provided as a powder or nutritional bar.
  • The appetite suppressing extract used in meal replacement could be prepared from plant material such as the stems and roots of said plants of the genus Trichocaulon or of the genus Hoodia. The genus Trichocaulon and the genus Hoodia include succulent plants growing in arid regions such as are found in Southern Africa. Besides possessing appetite suppressing and thirst quenching qualities, hoodia also possesses a sense of well being, and, anecdotal accounts regarding its aphrodisiac properties.
  • The present exemplary system and method extends also to a composition or formulation having appetite suppressant activity, in which the active ingredient is a synthetically produced version of Hoodia Gordonii, a member of the Caralluma group or a derivative or analogue thereof.
  • The present exemplary system and method extends also to a foodstuff or a beverage containing an effective quantity of the appetite suppressing Hoodia species, or its derivatives or analogues as set out before, to have an appetite suppressant effect when ingested. If in a powder form, which is reconstituted with water, milk or juice, the powder is to be mixed in any kind of ways, as in an electric blender or by simply shaking/stirring the powder and the liquid in a container. Alternatively, the powder could be agglomerated to facilitate reconstitution without an electric food blender.
  • A weight control meal replacement is formulated such that one serving of the beverage/bar/chocolate/soup/etc, acts as a meal replacement and provides any amount of United States Recommended Daily Allowance (US RDA) for protein, minerals and vitamins, fiber, and any amount of calories.
  • The preceding description has been presented only to illustrate and describe the present method and products. It is not intended to be exhaustive or to limit the disclosure to any precise form disclosed. Many modifications and variations are possible in light of the above teaching. It is intended that the scope of the present system and method be defined by the following claims.

Claims (25)

1. A meal replacement, comprising:
a meal replacement base, and
an appetite suppressant including a succulent plant extract.
2. The meal replacement of claim 1, wherein said succulent plant extract is selected from the group consisting of Trichocaulon piliferum, Trichocaulon officinale, Hoodia gordonii, Hoodia currorii, and Hoodia lugardii.
3. The meal replacement of claim 1, wherein said succulent plant extract is selected from the Caralluma group of plants.
4. The meal replacement or claim 3, wherein said succulent plant extract is selected from the group consisting of caralluma indica, caralluma fimbriata, caralluma attenuata, caralluma tuberculata, caralluma edulis, caralluma adscendens, caralluma stalagmifera, caralluma umbellata, caralluma penicillata, caralluma russeliana, caralluma retrospiciens, caralluma Arabica, and caralluma lasiantha.
5. The meal replacement of claim 1, wherein said meal replacement base includes a sugar substitute.
6. The meal replacement of claim 5, wherein said sugar substitute comprises a sugar alcohol.
7. The meal replacement of claim 6, wherein said sugar alcohol includes at least one of mannitol, sorbitol, xylitol, lactitol, isomalt, maltitol, erythritol, D-tagatose, trehalose, isomalt hydrogenated starch hydrolysates, or isomalt.
8. The meal replacement of claim 5, wherein said sugar substitute includes a fiber sweetener.
9. The meal replacement of claim 8, wherein said fiber sweeter includes at least one of inulin and oligofructose.
10. The meal replacement of claim 9, and further comprising at least one of guar gum, gum arabic, xanthan gum, carrageenan, and pectin.
11. The meal replacement of claim 9, wherein said sugar substitute includes a high intensity sweetener.
12. The meal replacement of claim 1, wherein said meal replacement base includes at least one protein selected from a group consisting of soy and soy isolates, whey and whey isolates, micro cross filtered whey isolates, wheat proteins, glutenir, gliadin, gluten, isolated grain and vegetable proteins, egg white protein, protein isolates, and albumen isolates.
13. The meal replacement of claim 1, wherein said meal replacement base includes at least one vegetable protein.
14. The meal replacement of claim 1, wherein said meal replacement base includes at least one protein-providing vegetables selected from a group consisting of spelt, quinoa, amaranth, buckwheat, and black rice.
15. The meal replacement of claim 1, wherein said meal replacement base includes at least one of vitamin A, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, para-aminobenzoic acid, Vitamin B2 (riboflavin), Vitamin B6, niacin, inositol, biotin, folic acid, choline, and vitamin B1, magnesium, iron, zinc, copper, manganese, sodium, potassium, calcium, selenium, chromium, molybdenum, chlorine, fluorine, phosphorus, sulfur, and iodine.
16. The meal replacement of claim 1, wherein said meal replacement base includes at least one of bilberry, cascara, cat's claw, cayenne, cranberry, devil's claw, dong quai, echinacea, evening primrose oil, feverfew, garlic, ginger, ginkgo, Asian ginseng, Siberian ginseng, goldenseal, gotu kola, grape seed, green tea, hawthorn, kava, licorice, milk thistle, noni, saw palmetto, St. John's wort, valerian, melatonin, damiana, yerbe mate, Rhodiola Rosea, camu-camu berries, Wolfberries, Acai, borojoa patinoi and guarana.
17. The meal replacement of claim 1, wherein said meal replacement is in the form of a dry powder mix, to be reconstituted with liquid.
18. The meal replacement of claim 1, wherein said meal replacement is in ready to drink packaging.
19. The meal replacement of claim 1, wherein said meal replacement is in the form of at least one of a group consisting of beverages, puddings, confections, ice cream, frozen confections and novelties, hot chocolate, coffee, tea, confectionaries, chocolates, nutritional/energy bars, soups, breads/cereals, probiotic drinks/yogurt/kefir, and chips.
20. The meal replacement of claim 1, wherein said meal replacement base includes a first portion of the appetite suppressant is in a form of a tablet/capsule/gel cap and a second portion is configured to be administered separately from said first portion.
21. A meal replacement, comprising:
a meal replacement base having a sugar substitute, a protein, fiber, vitamins and minerals; and
an appetite suppressant having a succulent plant extract is selected from the group consisting of Trichocaulon piliferum, Trichocaulon officinale, Hoodia gordonii, Hoodia currorii, Hoodia lugardii and the Caralluma group of plants.
22. The meal replacement of claim 21, wherein said meal replacement is in a ready to drink form.
23. The meal replacement of claim 21, wherein said meal replacement is in a powdered form.
24. The meal replacement of claim 21, wherein said meal replacement is in a bar form.
25. A method of forming a meal replacement, comprising:
providing a meal replacement base;
adding an appetite suppressant to said meal replacement base, said appetite suppressant including a succulent plant extract selected from the group consisting of Trichocaulon piliferum, Trichocaulon officinale, Hoodia gordonii, Hoodia currorii, Hoodia lugardii and the Caralluma group of plants.
US11/253,234 2004-10-19 2005-10-17 Meal replacement products having appetite suppressing qualities Abandoned US20060083795A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US11/253,234 US20060083795A1 (en) 2004-10-19 2005-10-17 Meal replacement products having appetite suppressing qualities
PCT/US2005/038239 WO2006045112A2 (en) 2004-10-19 2005-10-18 Meal replacement products having appetite suppressing qualities
EP05811893A EP1804585A4 (en) 2004-10-19 2005-10-18 Meal replacement products having appetite suppressing qualities

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62019504P 2004-10-19 2004-10-19
US11/253,234 US20060083795A1 (en) 2004-10-19 2005-10-17 Meal replacement products having appetite suppressing qualities

Publications (1)

Publication Number Publication Date
US20060083795A1 true US20060083795A1 (en) 2006-04-20

Family

ID=36181054

Family Applications (1)

Application Number Title Priority Date Filing Date
US11/253,234 Abandoned US20060083795A1 (en) 2004-10-19 2005-10-17 Meal replacement products having appetite suppressing qualities

Country Status (3)

Country Link
US (1) US20060083795A1 (en)
EP (1) EP1804585A4 (en)
WO (1) WO2006045112A2 (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070166275A1 (en) * 2006-01-19 2007-07-19 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US20070172542A1 (en) * 2005-07-18 2007-07-26 Next Proteins, Inc. Stimulant-containing nutrition bar product and method of manufacture
WO2007096239A1 (en) * 2006-02-23 2007-08-30 Unilever N.V. Appetite suppressant compositions
WO2007144347A3 (en) * 2006-06-13 2008-05-22 Unilever Nv Unit serving appetite suppressant compositions with steroidal glycosides
US20080233245A1 (en) * 2007-03-19 2008-09-25 Lesley Joan White Liquid nutrient composition for improving performance
US20090041902A1 (en) * 2007-08-10 2009-02-12 Jadwiga Malgorzata Bialek Composite food product in a pack comprising fibers and method for preparing such product
US20090220649A1 (en) * 2005-03-14 2009-09-03 Sapporo Holding Limited Nutritionally Balanced Food or Beverage Product
US20100124578A1 (en) * 2008-11-17 2010-05-20 Heuer Marvin A Appetite-suppressing weight management composition
US20100222422A1 (en) * 2009-03-02 2010-09-02 F.H.G. Corporation,d/b/a Integrity Nutraceuticals Dietary supplements containing extracts of aronia and methods of using same to promote weight loss
US20110003021A1 (en) * 2009-07-01 2011-01-06 Jason Christian Grovenor Halford Composition and method for reducing food intake
US8048456B2 (en) 2009-08-28 2011-11-01 Mary Kay Inc. Skin care formulations
CN102948762A (en) * 2011-08-25 2013-03-06 北京康比特体育科技股份有限公司 Composition for weight reduction and its preparation method and use
US20130287890A1 (en) * 2012-04-25 2013-10-31 Ueno Fine Chemicals Industry, Ltd. Inhibitor of the production of advanced glycation end products
US20140205719A1 (en) 2011-06-20 2014-07-24 Generale Biscuit Healthy layered cookie
WO2014176222A1 (en) * 2013-04-22 2014-10-30 University Of Florida Research Foundation, Inc. Nutritional supplement for weight management
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
WO2016196804A1 (en) * 2015-06-04 2016-12-08 Balchem Corporation Hydration control for choline salts
US9636373B1 (en) * 2016-02-09 2017-05-02 Kahouokalani Akao KAVA-based beverage composition
US9789151B2 (en) 2009-07-01 2017-10-17 Natures Remedies Ltd. Composition and method for reducing food intake
CN107874209A (en) * 2017-11-23 2018-04-06 何会平 A kind of ginkgo custard can for preventing cardiovascular and cerebrovascular disease
CN109845956A (en) * 2018-12-20 2019-06-07 北京长生堂国际中医药研究院 A kind of compound meal replacement powder and its production method
US10314326B2 (en) 2009-07-01 2019-06-11 Natures Remedies Ltd Composition for reducing food intake

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1897449A1 (en) * 2006-09-09 2008-03-12 Cognis IP Management GmbH Oral and /or topical compositions
AU2009325842A1 (en) * 2008-12-08 2011-07-14 Bio-Mass Ltd. Method of treatment of diseases using Hoodia extracts
US20100209557A1 (en) * 2009-02-14 2010-08-19 O'connor Daniel C Recovery blends for liquid beverages
WO2013067485A1 (en) * 2011-11-03 2013-05-10 University Of Florida Research Foundation, Inc. Nutritional supplement for weight management
CN104522812B (en) * 2014-12-30 2016-04-20 华南师范大学 A kind of Cordyceps sinensis viable bacteria beverage and production method thereof
CN104823668B (en) * 2015-05-13 2017-05-10 浙江大学 Application of Selenium in Improving Plant Endogenous Melatonin Content
CN108308598B (en) * 2017-12-22 2021-07-13 正大青春宝药业有限公司 Weight-losing meal replacement nutrition bar and preparation method thereof

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
US5859343A (en) * 1995-06-23 1999-01-12 University Of Hawaii Recombinant sweet protein mabinlin
US5994295A (en) * 1995-06-06 1999-11-30 Campbell Soup Company Therapeutic system for dietary health management
US6149965A (en) * 1998-01-12 2000-11-21 General Mills, Inc. Cereal products with inulin and methods of preparation
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
US6376657B1 (en) * 1997-04-15 2002-04-23 Csir Pharmaceutical compositions having appetite suppressant activity
US20030152648A1 (en) * 2001-11-16 2003-08-14 Corley David Gregory Plant derived or derivable material with appetite suppressing activity
US20040265398A1 (en) * 2002-04-25 2004-12-30 Fleischner Albert M. Herbal composition for weight control
US20050163871A1 (en) * 2003-06-04 2005-07-28 Ramaswamy Rajendran Caralluma extract products and processes for making the same
US20050276869A1 (en) * 2004-06-14 2005-12-15 Century Systems Appetite-suppressing, lipase-inhibiting herbal composition
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363985B (en) * 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
CA2563237C (en) * 2004-04-07 2012-10-09 Rutgers, The State University Of New Jersey Appetite-suppressing compositions and methods
JP5345778B2 (en) * 2004-04-27 2013-11-20 ラジェンドラン，ラムズワーミー Use of pregnane glycosides in the treatment / management of obesity, obesity related disorders, and other disorders

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
US5994295A (en) * 1995-06-06 1999-11-30 Campbell Soup Company Therapeutic system for dietary health management
US5859343A (en) * 1995-06-23 1999-01-12 University Of Hawaii Recombinant sweet protein mabinlin
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
US6376657B1 (en) * 1997-04-15 2002-04-23 Csir Pharmaceutical compositions having appetite suppressant activity
US6149965A (en) * 1998-01-12 2000-11-21 General Mills, Inc. Cereal products with inulin and methods of preparation
US20030152648A1 (en) * 2001-11-16 2003-08-14 Corley David Gregory Plant derived or derivable material with appetite suppressing activity
US20040265398A1 (en) * 2002-04-25 2004-12-30 Fleischner Albert M. Herbal composition for weight control
US20050163871A1 (en) * 2003-06-04 2005-07-28 Ramaswamy Rajendran Caralluma extract products and processes for making the same
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
US20050276869A1 (en) * 2004-06-14 2005-12-15 Century Systems Appetite-suppressing, lipase-inhibiting herbal composition

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090220649A1 (en) * 2005-03-14 2009-09-03 Sapporo Holding Limited Nutritionally Balanced Food or Beverage Product
US20070172542A1 (en) * 2005-07-18 2007-07-26 Next Proteins, Inc. Stimulant-containing nutrition bar product and method of manufacture
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
US10918591B2 (en) 2006-01-19 2021-02-16 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US10668124B2 (en) 2006-01-19 2020-06-02 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US12186357B2 (en) 2006-01-19 2025-01-07 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US10130673B2 (en) 2006-01-19 2018-11-20 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US10675323B2 (en) 2006-01-19 2020-06-09 Mary Kay Inc. Topical compositions comprising acai berry extract
US20070166275A1 (en) * 2006-01-19 2007-07-19 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US20080003268A1 (en) * 2006-02-23 2008-01-03 Conopco Inc., D/B/A Unilever Unit serving appetite suppressant compositions with steroidal glycosides
WO2007096239A1 (en) * 2006-02-23 2007-08-30 Unilever N.V. Appetite suppressant compositions
WO2007144347A3 (en) * 2006-06-13 2008-05-22 Unilever Nv Unit serving appetite suppressant compositions with steroidal glycosides
US20080233245A1 (en) * 2007-03-19 2008-09-25 Lesley Joan White Liquid nutrient composition for improving performance
US20090041902A1 (en) * 2007-08-10 2009-02-12 Jadwiga Malgorzata Bialek Composite food product in a pack comprising fibers and method for preparing such product
WO2009021834A1 (en) * 2007-08-10 2009-02-19 Unilever N.V. Composite food product in a pack comprising fibers and method for preparing such product
US20100124578A1 (en) * 2008-11-17 2010-05-20 Heuer Marvin A Appetite-suppressing weight management composition
US20100222422A1 (en) * 2009-03-02 2010-09-02 F.H.G. Corporation,d/b/a Integrity Nutraceuticals Dietary supplements containing extracts of aronia and methods of using same to promote weight loss
US8445035B2 (en) 2009-03-02 2013-05-21 Fhg Corporation Dietary supplements containing extracts of aronia and method of using same to promote weight loss
US8158683B2 (en) 2009-03-02 2012-04-17 Fhg Corporation Dietary supplements containing extracts of aronia and methods of using same to promote weight loss
US10314326B2 (en) 2009-07-01 2019-06-11 Natures Remedies Ltd Composition for reducing food intake
US9789151B2 (en) 2009-07-01 2017-10-17 Natures Remedies Ltd. Composition and method for reducing food intake
US20110003021A1 (en) * 2009-07-01 2011-01-06 Jason Christian Grovenor Halford Composition and method for reducing food intake
US8470377B2 (en) 2009-07-01 2013-06-25 Natures Remedies Ltd. Composition and method for reducing food intake
AU2010267652B2 (en) * 2009-07-01 2014-04-17 Natures Remedies Ltd. Composition and method for reducing food intake
US8048456B2 (en) 2009-08-28 2011-11-01 Mary Kay Inc. Skin care formulations
US11123578B2 (en) 2009-08-28 2021-09-21 Mary Kay Inc. Skin care formulations
US12097393B2 (en) 2009-08-28 2024-09-24 Mary Kay Inc. Skin care formulations
US9833642B2 (en) 2009-08-28 2017-12-05 Mary Kay Inc. Skin care formulations
US8895082B2 (en) 2009-08-28 2014-11-25 Mary Kay Inc. Skin care formulations
US11679284B2 (en) 2009-08-28 2023-06-20 Mary Kay Inc. Skin care formulations
US8691300B2 (en) 2009-08-28 2014-04-08 Mary Kay Inc. Skin care formulations
US10434340B2 (en) 2009-08-28 2019-10-08 Mary Kay Inc. Skin care formulations
US11596813B2 (en) 2009-08-28 2023-03-07 Mary Kay Inc. Skin care formulations
US10306897B2 (en) 2011-06-20 2019-06-04 Generale Biscuit Breakfast biscuit with slowly available glucose
US10357041B2 (en) 2011-06-20 2019-07-23 Generale Biscuit Healthy layered cookie
US20140205719A1 (en) 2011-06-20 2014-07-24 Generale Biscuit Healthy layered cookie
US9883679B2 (en) 2011-06-20 2018-02-06 Generale Biscuit Biscuit dough
CN102948762A (en) * 2011-08-25 2013-03-06 北京康比特体育科技股份有限公司 Composition for weight reduction and its preparation method and use
US20130287890A1 (en) * 2012-04-25 2013-10-31 Ueno Fine Chemicals Industry, Ltd. Inhibitor of the production of advanced glycation end products
WO2014176222A1 (en) * 2013-04-22 2014-10-30 University Of Florida Research Foundation, Inc. Nutritional supplement for weight management
WO2016196804A1 (en) * 2015-06-04 2016-12-08 Balchem Corporation Hydration control for choline salts
US9636373B1 (en) * 2016-02-09 2017-05-02 Kahouokalani Akao KAVA-based beverage composition
CN107874209A (en) * 2017-11-23 2018-04-06 何会平 A kind of ginkgo custard can for preventing cardiovascular and cerebrovascular disease
CN109845956A (en) * 2018-12-20 2019-06-07 北京长生堂国际中医药研究院 A kind of compound meal replacement powder and its production method

Also Published As

Publication number Publication date
WO2006045112A3 (en) 2006-09-21
EP1804585A4 (en) 2010-03-17
EP1804585A2 (en) 2007-07-11
WO2006045112A2 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
US20060083795A1 (en) Meal replacement products having appetite suppressing qualities
ES2230573T3 (en) ANTI-OBESITY AGENT WHOSE ACTIVE PRINCIPLE IS PROCIANIDINE.
AU2002364298B2 (en) Stimulation of the immune system with polydextrose
RU2391863C2 (en) Polyphenol containing composition and isomaltose preparation
US20010018090A1 (en) Calorie reducing agent
CA2773134A1 (en) Sweetness enhancers including rebaudioside a or d
JP2008291002A (en) Composition for preventing, improving or treating metabolic syndrome
JPH11335285A (en) Intestinal controlling and constipation improving medicine and food and drink, and animal feed containing the same
JP5442243B2 (en) Renal disorder inhibitor
WO2005006891A1 (en) Carbohydrate substitute
JP2011254749A (en) Mannose-containing composition
JP3462535B2 (en) Mineral absorption promoting composition
JP2009249320A (en) Obesity- and diabetes-ameliorating agent
Antonik et al. Characteristics of sweeteners used in foods and their effects on human health
CN1723033A (en) Composition for reducing caloric intake
WO2015118699A1 (en) Satiety maintaining agent and method for maintaining feeling of satisfaction
JP2002193823A (en) Medicine for preventing drunken sickness and hangover
CN110710672A (en) Natural plant active calcium preparation and preparation method thereof
KR102478971B1 (en) Composition for bowel movement promotion or diet
JP2003095941A (en) Carbohydrate digestive enzyme inhibitor, blood sugar rise inhibitor, obesity treatment / prevention agent, diabetes treatment / prevention agent, healthy food and drink
KR102510297B1 (en) A composition for the prevention or treatment of depression, stress or memory malfunctions containing Erythronium japonicum extract
KR20170061656A (en) Composition for preventing, improving or treating diabetes comprising osmotin peptide as effective component
GUPTA et al. TWO WHITE ENEMIES: SALT AND SUGAR: 1I. CONSUMPTION OF SUGAR: PROS AND CONS
Chaudhry et al. A short communication on sweeteners and their relative profiles
JP2007070263A (en) Composition for preventing diabetes mellitus

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载